Disciplined Growth Investors Inc Myriad Genetics Inc Call Options Transaction History
Disciplined Growth Investors Inc
- $5.44 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MYGN
# of Institutions
191Shares Held
94.2MCall Options Held
280KPut Options Held
14.3K-
Black Rock Inc. New York, NY14.9MShares$368 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$248 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.06MShares$200 Million0.03% of portfolio
-
Camber Capital Management LP Boston, MA7.64MShares$189 Million3.99% of portfolio
-
State Street Corp Boston, MA5.4MShares$134 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $2B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...